Clinical trials
Humans clinical trials
Below are recruiting humans clinical trials, each written for real people, not researchers. We’re tracking 1,242 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06944067Recruiting
Genetic risk of immune response after blood transfusions in sickle cell disease
This study looks at whether certain genes make people with sickle cell disease more likely to develop an immune reaction to blood transfusions. It aims to help doctors predict transfusion risks and improve care.
Bethesda, MarylandAges 2–99 - NCT06944223Recruiting
Citrate and oxalate study for people with or without kidney stones
This study looks at how your body handles citrate and oxalate, two substances related to kidney stones. You can join whether you've had kidney stones or not, as long as your citrate and oxalate levels are not too high or too low.
Chicago, IllinoisAges 18–70 - NCT06956209Recruiting
Akyva implant for underactive bladder first human trial
This trial tests a new implant called Akyva for people with underactive bladder (not enough bladder muscle contraction). It may help you empty your bladder better without needing catheters as often.
Woolloongabba, QueenslandAges 22 years+ - NCT06958796RecruitingPhase 4
CMV immunoglobulin to prevent disease after transplant
This trial tests whether giving CMV immunoglobulin (an antibody medicine) after transplant can help prevent a serious CMV infection in people who receive a kidney or liver from a CMV-positive donor. You might be eligible if you are getting one of these transplants and are at high risk for CMV.
Boston, MassachusettsAges 18–75 - NCT06966414Recruiting
Timing of bodyweight exercise on behavior
This trial tests how doing bodyweight exercises at different times of the day affects your behavior. If you're generally inactive but healthy, it might help find the best time to exercise for you.
TaipeiAges 20–50 - NCT06967311Recruiting
What causes IBD flare-ups?
This study looks at how your body and gut germs may trigger flare-ups of inflammatory bowel disease (IBD). It may help doctors understand and predict when symptoms come back.
Florianópolis, Santa CatarinaAges 18 years+ - NCT06968936Recruiting
Long-term outcomes of pre-surgery iron therapy
This study looks at long-term results of giving iron before major heart surgery to people with low iron levels. It aims to see if this treatment helps recovery and outcomes.
Hangzhou, ZhejiangAges 18–85 - NCT06997484RecruitingPhase 1
Testing safety of HL-400 in healthy adults
This study tests a new drug called HL-400 for the first time in people. It checks how safe the drug is and how the body handles it, to see if it could be developed for future patients.
Baltimore, MarylandAges 18–65 - NCT07008703RecruitingPhase 1/Phase 2
Study of sss40 for cancer bone pain
This trial tests a new injection called sss40 to treat moderate-to-severe pain caused by cancer that has spread to the bones. The goal is to see if it is safe and effective for people whose pain is not being controlled by current treatments.
Zhengzhou, HenanAges 18 years+ - NCT07013110RecruitingPhase 2
AI-guided precision therapy for active rheumatoid arthritis
This study tests a new, AI-powered treatment approach for rheumatoid arthritis. It's for people with active disease who haven't used certain biologic or targeted therapies in the last 6 months.
SingaporeAges 21 years+ - NCT07016802RecruitingPhase 1
Study of GenSci134 for growth hormone deficiency
This trial tests a new growth hormone treatment called GenSci134 in healthy adults and adults with growth hormone deficiency (AGHD). The goal is to see if it is safe and effective for people who need growth hormone replacement.
Beijing, Beijing MunicipalityAges 18–70 - NCT07016997RecruitingPhase 1
A study of CBA-1535 for advanced solid tumors
This trial tests a new drug, CBA-1535, which is designed to help your immune system attack cancer cells. It is for people with advanced solid tumors who have run out of standard treatment options or cannot tolerate them.
Nagaizumicho, ShizuokaAges 20 years+ - NCT07020611Recruiting
Lining Aneurysm Sac in Abdominal Aortic Aneurysm
This early study tests a new device that lines the aneurysm sac (the outer wall) during standard stent-graft repair for abdominal aortic aneurysm. It aims to see if the lining helps prevent the aneurysm from growing or leaking over time.
AucklandAges 18 years+ - NCT07027735Recruiting
Placental tissue patch for rotator cuff repair
This trial tests a patch made from donated human placental tissue to help heal full-thickness rotator cuff tears during surgery. It may improve recovery and reduce the risk of re-tearing.
New York, New YorkAges 18 years+ - NCT07030920RecruitingPhase 2
Reducing inflammation in people living with HIV
This trial tests if a drug can lower inflammation in people with HIV who are on effective treatment. It may help reduce the risk of heart disease and other problems related to chronic inflammation.
Montreal, QuebecAges 18 years+ - NCT07033091Recruiting
HPV screening study for healthy adults 40 and older
This study checks healthy adults aged 40+ for HPV in the mouth using a simple gargle rinse. It aims to see if this can help find early signs of oropharyngeal cancer.
BrnoAges 40 years+ - NCT07034183RecruitingPhase 1
First test of PRD001 in healthy volunteers
This first-in-human study tests a new drug called PRD001 in healthy volunteers. It's checking how safe the drug is and how the body handles it, with a focus on people of Japanese and Caucasian ancestry.
Fukuoka, FukuokaAges 18–60 - NCT07035769RecruitingPhase 1
Debio 1453P safety study in healthy adults
This trial tests an experimental oral drug, Debio 1453P, for the first time in people. Healthy adults can take part to see if the drug is safe and how the body processes it.
EdegemAges 18–55 - NCT07036107Recruiting
Exoskeleton rehab for spinal cord injury in Spain
This trial tests whether a wearable exoskeleton can help people with recent spinal cord injury improve their walking ability and quality of life. It focuses on patients treated in the Spanish healthcare system.
Toledo, Castille-La ManchaAges 18–70 - NCT07038382RecruitingPhase 2
Study of HLX79 with Rituximab for Active Kidney Disease
This trial tests a new drug called HLX79 (a human sialidase fusion protein) combined with rituximab, compared to a placebo, for people with active membranous nephropathy (a kidney disease). It aims to see if this combination can reduce protein in the urine and improve kidney function.
BeijingAges 18–75 - NCT07040397Recruiting
Massage therapy study for lower back pain
This study tests whether an electronic approach to massage therapy can help relieve lower back pain. It may be an option if you have persistent lower back pain and haven't used pain medications recently.
Rochester, MinnesotaAges 18 years+ - NCT07041801RecruitingPhase 1/Phase 2
Stem cell therapy for lupus patients
This trial tests whether a type of stem cell from umbilical cords can help people with systemic lupus erythematosus (an autoimmune disease). It aims to find a new way to reduce lupus symptoms and improve quality of life.
Shenzhen, GuangdongAges 18–65 - NCT07047677Recruiting
Tissue binding study of experimental radioactive markers
This study uses leftover tissue from surgeries to test how experimental radioactive markers bind to human tissue. It helps researchers understand how these markers might work for future imaging or treatments.
Vandœuvre-lès-NancyAges 18–99 - NCT07047703RecruitingPhase 1/Phase 2
A study of an experimental drug for axial spondyloarthritis
This trial tests an investigational drug for people with axial spondyloarthritis (a type of inflammatory arthritis affecting the spine and pelvis). It also includes a group of healthy volunteers for comparison. The study aims to see if the drug is safe and effective.
BirtinyaAges 18–65
Hear when a new Humans trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for humans?
- Yes. Clin2 currently lists 1,242 recruiting humans studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a humans trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a humans trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.